Novel compound heterozygous PLEC mutations lead to early‑onset limb‑girdle muscular dystrophy 2Q

Zhong,Jingzi; Chen,Gang; Dang,Yiwu; Liao,Haixia; Zhang,Jiapeng; Lan,Dan

doi:10.3892/mmr.2017.6309

Novel compound heterozygous PLEC mutations lead to early‑onset limb‑girdle muscular dystrophy 2Q

Authors:
- Jingzi Zhong
- Gang Chen
- Yiwu Dang
- Haixia Liao
- Jiapeng Zhang
- Dan Lan
View Affiliations

Affiliations: Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China
Published online on: March 9, 2017 https://doi.org/10.3892/mmr.2017.6309
Pages: 2760-2764

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Limb-girdle muscular dystrophy 2Q (LGMD2Q) is a specific mutation in the plectin (PLEC1) gene at chromosome 8q24.3. In the present study, targeted sequencing using a muscle disease gene panel was performed in a patient with muscular dystrophy. The family members were confirmed by Sanger sequencing. The PolyPhen‑2, SIFT and MutationTaster tools were used to predicted the possible effect of the mutations. Immunocytochemistry was used to visualize and localize the plectin protein within the gastrocnemius. Novel compound heterozygous mutations c.5995C>T (p.Arg1999Trp) and c.9940T>A (p.Phe3314 Ile) in the PLEC gene were identified to be the genetic cause of LGMD2Q in this family. These variants were absent in 200 normal controls. Furthermore, defects in the plectin protein within the gastrocnemius were determined using immunocytochemistry. To the best of our knowledge, the present study provides the second report on plectin‑associated LGMD2Q without other symptoms, although the genotype identified was novel. The missense mutations in the proband were considered to be an explanation for the symptom. These findings extend current knowledge of the mutation spectrum of the PLEC gene associated with LGMD2Q.

View Figures

View References

1	Narayanaswami P, Weiss M, Selcen D, David W, Raynor E, Carter G, Wicklund M, Barohn RJ, Ensrud E, Griggs RC, et al: Evidence-based guideline summary: Diagnosis and treatment of limb-girdle and distal dystrophies: Report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology. 83:1453–1463. 2014. View Article : Google Scholar : PubMed/NCBI
2	Nigro V, Aurino S and Piluso G: Limb girdle muscular dystrophies: Update on genetic diagnosis and therapeutic approaches. Curr Opin Neurol. 24:429–436. 2011. View Article : Google Scholar : PubMed/NCBI
3	Bushby KM: Diagnostic criteria for the limb-girdle muscular dystrophies: Report of the ENMC consortium on limb-girdle dystrophies. Neuromuscul Disord. 5:71–74. 1995. View Article : Google Scholar : PubMed/NCBI
4	Winter L and Wiche G: The many faces of plectin and plectinopathies: Pathology and mechanisms. Acta Neuropathol. 125:77–93. 2013. View Article : Google Scholar : PubMed/NCBI
5	Gundesli H, Talim B, Korkusuz P, Balci-Hayta B, Cirak S, Akarsu NA, Topaloglu H and Dincer P: Mutation in exon 1f of PLEC, leading to disruption of plectin isoform 1f, causes autosomal-recessive limb-girdle muscular dystrophy. Am J Hum Genet. 87:834–841. 2010. View Article : Google Scholar : PubMed/NCBI
6	Emery AE: Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord. 1:19–29. 1991. View Article : Google Scholar : PubMed/NCBI
7	Schwarz JM, Cooper DN, Schuelke M and Seelow D: MutationTaster2: Mutation prediction for the deep-sequencing age. Nat Methods. 11:361–362. 2014. View Article : Google Scholar : PubMed/NCBI
8	Scott OM, Hyde SA, Goddard C and Dubowitz V: Quantitation of muscle function in children: A prospective study in Duchenne muscular dystrophy. Muscle Nerve. 5:291–301. 1982. View Article : Google Scholar : PubMed/NCBI
9	Wiche G: Plectin: General overview and appraisal of its potential role as a subunit protein of the cytomatrix. Crit Rev Biochem Mol Biol. 24:41–67. 1989. View Article : Google Scholar : PubMed/NCBI
10	Wiche G, Krepler R, Artlieb U, Pytela R and Denk H: Occurrence and immunolocalization of plectin in tissues. J Cell Biol. 97:887–901. 1983. View Article : Google Scholar : PubMed/NCBI
11	Zhang T, Haws P and Wu Q: Multiple variable first exons: A mechanism for cell- and tissue-specific gene regulation. Genome Res. 14:79–89. 2004. View Article : Google Scholar : PubMed/NCBI
12	Fuchs P, Zörer M, Rezniczek GA, Spazierer D, Oehler S, Castañón MJ, Hauptmann R and Wiche G: Unusual 5′ transcript complexity of plectin isoforms: Novel tissue-specific exons modulate actin binding activity. Hum Mol Genet. 8:2461–2472. 1999. View Article : Google Scholar : PubMed/NCBI
13	Gache Y, Chavanas S, Lacour JP, Wiche G, Owaribe K, Meneguzzi G and Ortonne JP: Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest. 97:2289–2298. 1996. View Article : Google Scholar : PubMed/NCBI
14	McLean WH, Pulkkinen L, Smith FJ, Rugg EL, Lane EB, Bullrich F, Burgeson RE, Amano S, Hudson DL, Owaribe K, et al: Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev. 10:1724–1735. 1996. View Article : Google Scholar : PubMed/NCBI
15	Rouan F, Pulkkinen L, Meneguzzi G, et al: Epidermolysis bullosa: novel and de novo premature termination codon and deletion mutations in the plectin gene predict late-onset muscular dystrophy. J Invest Dermatol. 114:381–387. 2000. View Article : Google Scholar : PubMed/NCBI